Diabetes & its Complications

Diabetes & its Complications

Open Access
ISSN: 2639-9326
Original Research Article

The Value of Ankle-Brachial Index (ABI) Measurement in Hypertensive Diabetic Patients: A Case Report and Literature Review

Authors: Ibrahima A Dembélé, Stéphane L Djeugoue, Kaly Keïta, Landouré Sekou, Mamadou Cissoko, Adama Sinayoko, Ama Sangaré, Assitan Soumaré, Achta A A Hassane, Aoua Diarra, Yacouba Koné, Samuelle N Abolo, Djeri A Oupidja, Sanaba Diakité, Coulibaly Djénéba, Clémence S Kpokou, Altinè Togo, Tinahil M Mohamedine, Camara Samba, Nouhoum Koné, Moussa Sangaré, Romuald Nyanké, Mamadou Mallé, Sy Djibril, Djénébou Traoré, Didier M Tshialala, Abrar-Ahmad Zulfiqar, Kaya A Soukho.

DOI: 10.33425/2639-9326.1137


Abstract

Introduction: The ankle-brachial index (ABI) is a simple, non-invasive, and reproducible tool for screening for peripheral artery disease (PAD). In hypertensive diabetic patients, cardiovascular risk is increased, and arterial disease is often asymptomatic.
Observation: We report the case of a 69-year-old woman, followed for type 2 diabetes mellitus and hypertension, in whom systematic ABI measurement led to the diagnosis of subclinical PAD, prompting a reassessment of overall cardiovascular risk and intensified treatment. The ABI has major diagnostic and prognostic value in hypertensive diabetic patients. Its predictive value for cardiovascular events is demonstrated, independent of other risk factors.
Conclusion: Systematic ABI measurement should be integrated into the cardiovascular assessment of hypertensive diabetic patients to optimize secondary and enhanced primary prevention.
Keywords: Systolic blood pressure index, Peripheral arterial disease, Cardiovascular risk, Internal Medicine.

View / Download PDF
Citation: Ibrahima A Dembélé, Stéphane L Djeugoue, Kaly Keïta, et al. The Value of Ankle-Brachial Index (ABI) Measurement in Hypertensive Diabetic Patients: A Case Report and Literature Review. Diabetes Complications. 2026; 10(2). DOI: 10.33425/2639-9326.1137
Editor-in-Chief
Parijat De
Parijat De
Department of Diabetes Endocrinology & Metabolism | City Hospital

View full editorial board →
Journal Metrics
Impact Factor 2.6*
Acceptance Rate 78%
Time to first decision 5-8 Days
Submission to acceptance 12-15 Days